USD 7.59
(4.55%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -17.84 Million USD | -313.98% |
2022 | -4.31 Million USD | -4.79% |
2021 | -4.11 Million USD | -60.33% |
2020 | -2.56 Million USD | -526.13% |
2019 | -409.73 Thousand USD | -4633.41% |
2018 | 9038.00 USD | -96.87% |
2017 | 288.98 Thousand USD | 110.47% |
2016 | -2.76 Million USD | -147.06% |
2015 | -1.11 Million USD | 44.48% |
2014 | -2.01 Million USD | 3.79% |
2013 | -2.09 Million USD | -1287.59% |
2012 | -150.71 Thousand USD | 0.0% |
2008 | -28.49 Million USD | -101003.38% |
2007 | -28.18 Thousand USD | -223.05% |
2006 | -8725.00 USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -8.43 Million USD | 27.96% |
2024 Q2 | -1.83 Million USD | 78.27% |
2023 Q4 | -11.71 Million USD | -232.36% |
2023 FY | -17.84 Million USD | -313.98% |
2023 Q1 | -62.39 Thousand USD | 96.47% |
2023 Q2 | -1.97 Million USD | -3065.27% |
2023 Q3 | -3.52 Million USD | -78.5% |
2022 FY | -4.31 Million USD | -4.79% |
2022 Q4 | -1.76 Million USD | -251.37% |
2022 Q2 | -1.08 Million USD | -13.36% |
2022 Q3 | -503 Thousand USD | 53.59% |
2022 Q1 | -956.04 Thousand USD | -21.89% |
2021 Q3 | -1.3 Million USD | 49.51% |
2021 FY | -4.11 Million USD | -60.33% |
2021 Q4 | -784.34 Thousand USD | 39.75% |
2021 Q1 | -651.51 Thousand USD | 71.82% |
2021 Q2 | -2.57 Million USD | -295.73% |
2020 Q4 | -2.31 Million USD | -1770.74% |
2020 Q2 | -542.58 Thousand USD | -400.93% |
2020 Q1 | 180.3 Thousand USD | 136.41% |
2020 Q3 | 138.39 Thousand USD | 125.51% |
2020 FY | -2.56 Million USD | -526.13% |
2019 FY | -409.73 Thousand USD | -4633.41% |
2019 Q4 | -495.2 Thousand USD | -1896.49% |
2019 Q2 | 57.98 Thousand USD | -53.7% |
2019 Q1 | 125.22 Thousand USD | 166.61% |
2019 Q3 | 27.56 Thousand USD | -52.46% |
2018 Q2 | 20.51 Thousand USD | -75.07% |
2018 Q1 | 82.26 Thousand USD | -41.2% |
2018 Q4 | -187.99 Thousand USD | -299.46% |
2018 Q3 | 94.24 Thousand USD | 359.46% |
2018 FY | 9038.00 USD | -96.87% |
2017 Q3 | 76.19 Thousand USD | 1213.61% |
2017 FY | 288.98 Thousand USD | 110.47% |
2017 Q4 | 139.9 Thousand USD | 83.62% |
2017 Q2 | -6842.00 USD | -108.58% |
2017 Q1 | 79.72 Thousand USD | 117.99% |
2016 Q2 | -1.1 Million USD | -195.88% |
2016 FY | -2.76 Million USD | -147.06% |
2016 Q3 | -842.88 Thousand USD | 23.5% |
2016 Q1 | -372.38 Thousand USD | 24.84% |
2016 Q4 | -443.05 Thousand USD | 47.44% |
2015 Q3 | -123.76 Thousand USD | -127.69% |
2015 FY | -1.11 Million USD | 44.48% |
2015 Q1 | -443.62 Thousand USD | -1.48% |
2015 Q2 | -54.35 Thousand USD | 87.75% |
2015 Q4 | -495.44 Thousand USD | -300.32% |
2014 Q2 | -301.02 Thousand USD | 67.35% |
2014 Q3 | -351.88 Thousand USD | -16.9% |
2014 Q1 | -921.99 Thousand USD | 35.91% |
2014 Q4 | -437.14 Thousand USD | -24.23% |
2014 FY | -2.01 Million USD | 3.79% |
2013 FY | -2.09 Million USD | -1287.59% |
2013 Q3 | -283.67 Thousand USD | -53.76% |
2013 Q1 | -184.58 Thousand USD | 0.0% |
2013 Q2 | -184.49 Thousand USD | 0.05% |
2013 Q4 | -1.43 Million USD | -407.09% |
2012 FY | -150.71 Thousand USD | 0.0% |
2009 Q3 | -4531.00 USD | -73.87% |
2009 Q1 | -11.89 Thousand USD | 99.96% |
2009 Q2 | -2606.00 USD | 78.1% |
2008 Q4 | -28.47 Million USD | -715824.56% |
2008 Q2 | -6462.00 USD | 8.73% |
2008 Q1 | -7080.00 USD | 17.66% |
2008 FY | -28.49 Million USD | -101003.38% |
2008 Q3 | -3978.00 USD | 38.44% |
2007 Q3 | -7256.00 USD | 38.06% |
2007 Q2 | -11.71 Thousand USD | -1795.47% |
2007 Q1 | -618.00 USD | 80.56% |
2007 FY | -28.18 Thousand USD | -223.05% |
2007 Q4 | -8598.00 USD | -18.5% |
2006 Q3 | -1578.00 USD | 59.96% |
2006 FY | -8725.00 USD | 0.0% |
2006 Q4 | -3179.00 USD | -101.46% |
2006 Q2 | -3941.00 USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
CannBioRx Life Sciences Corp. | -19.93 Million USD | 10.492% |
BIMI International Medical Inc. | -22.35 Million USD | 20.173% |
China Jo-Jo Drugstores, Inc. | -4.23 Million USD | -321.413% |
Harrow Health, Inc. 8.625% Senior Notes due 2026 | -24.41 Million USD | 26.904% |
Harrow Health, Inc. 11.875% Senior Notes due 2027 | -24.41 Million USD | 26.904% |
Leafly Holdings, Inc. | -9.49 Million USD | -87.867% |
Leafly Holdings, Inc. | -9.49 Million USD | -87.867% |
LifeMD, Inc. | -20.59 Million USD | 13.364% |
LifeMD, Inc. | -20.59 Million USD | 13.364% |
PetMed Express, Inc. | -7.46 Million USD | -139.062% |
Walgreens Boots Alliance, Inc. | -8.63 Billion USD | 99.793% |